ÔÚÕâ¸öÒÔ¡°°×Ó×ÊÝ¡±ÎªÖ÷Á÷ÉóÃÀµÄʱ´ú£¬·ÊÅÖÈ´ÔÚÈ«ÊÀ½ç·¶Î§ÄÚÔ½À´Ô½¡°Ê¢ÐС±¡£ÉõÖÁÓз»¼äÏ·ÚÊ³Æ ¡°ÈýÈËÐУ¬±ØÓÐÒ»ÅÖ¡±¡£
¸ù¾ÝÊÀ½çÎÀÉú×éÖ¯£¨WHO£©µÄ¶¨Ò壬³¬ÖغͷÊÅÖÊÇ¿ÉË𺦽¡¿µµÄÒì³£»ò¹ýÁ¿Ö¬·¾ÀÛ»ý¡£³ÉÈËͨ³£ÓÃÉíÌåÖÊÁ¿Ö¸Êý£¨BMI£©À´½øÐг¬ÖغͷÊÅֵĶ¨Òå¡£ÆäÖУ¬WHO¶Ô³ÉÈ˳¬ÖصĶ¨ÒåΪBMI¡Ý25 kg/m2£¬·ÊÅÖΪBMI¡Ý30 kg/m2¡£
´ó¼Ò¶¼ÖªµÀ£¬·ÊÅÖÊÇÐí¶àÑÏÖؼ²²¡(°üÀ¨ÐÄÔ༲²¡¡¢´úл×ÛºÏÕ÷ÉõÖÁÖзçµÈ)µÄÖØÒª·çÏÕÒòËØ¡£Ò²ÓÐÐí¶à´óÐÍÁ÷Ðв¡Ñ§Ñо¿ÆÀ¹ÀÁË·ÊÅÖºÍËÀÍöÂÊÖ®¼äµÄ¹Øϵ¡£ÌرðÊÇ£¬¶Ô°üÀ¨3000¶àÍòÈËÔÚÄÚµÄ230Ïî¶ÓÁÐÑо¿µÄÜöÝÍ·ÖÎö·¢ÏÖ£¬·ÊÅֺͳ¬Öض¼ÓëÈ«ÒòËÀÍö·çÏÕÔö¼ÓÓйء£¾¡¹ÜÈç´Ë£¬µ«ÈÔÓÐһЩÑо¿µÃ³ö½áÂÛ£¬BMIÉý¸ß¿ÉÄÜ»áÌá¸ßÐÄѪ¹Ü¼²²¡»¼ÕߵĴæ»îÂÊ£¬ÕâÖÖÏÖÏó±»³ÆΪ¡°·ÊÅÖã£ÂÛ¡±¡£
½üÆÚ£¬À´×ÔÃÀ¹úÂíЪ¶û´óѧµÄѧÕßÔÚiScienceÔÓÖ¾ÉÏ·¢±íÁËÒ»ÏîÑõ»¯¼Á·Å´óÑ»·µÄÑо¿£¬½á¹û½ÒʾÁËÖ¬·¾Ï¸°ûÔÚÈÏÖªÄÜÁ¦Ï½µºÍÉñ¾±äÐÔÖеÄ×÷Óá£
¸ÃÑо¿±íÃ÷£¬Ö¬·¾Ï¸°û¿ØÖÆ×Å´óÄÔ¹¦ÄܵÄϵͳ·´Ó¦£¬µ¼ÖÂСÊóµÄ¼ÇÒäºÍÈÏÖªÄÜÁ¦ÊÜËð¡£Na£¬K-ATPase£¨ÄƼر㩼¤»îÓ°ÏìÁËÖ¬·¾Ï¸°ûÒÔ¼°º£ÂíÌ壨´óÄÔÖÐÓë¼ÇÒäºÍÈÏÖªÓйصIJ¿·Ö£©ÖÐÖØÒªµ°°×±ê¼ÇÎïµÄ±í´ï£¬Õâ»á¶ñ»¯´óÄÔ¹¦Äܲ¢µ¼ÖÂÉñ¾ÍË»¯¡£°ÐÏòÖ¬·¾Ï¸°ûÒÔÞ׿¹ÄƼرÃÔò¿ÉÒÔ¸ÄÉÆÉñ¾ÍËÐÐÐÔ±íÏÖ¡£
ÂÛÎĵÄÖ÷Òª×÷Õß¡¢ÂíЪ¶û´óѧJoan C. EdwardsҽѧԺ½ÌÊÚ¼æÔº³¤Joseph I Shapiroҽѧ²©Ê¿Ëµ£º¡°ÎÒÃÇÖ¼ÔÚÖ¤Ã÷Na£¬K-ATPaseÐźŴ«µ¼£¬ÌرðÊÇÔÚÖ¬·¾Ï¸°ûÖУ¬ÔÚÓÕ·¢´óÄÔÌض¨ÇøÓòµÄ¸Ä±äÖз¢»ÓºËÐÄ×÷Óá£ÆäÖÐ×îÃ÷ÏÔµÄÊÇÔÚº£ÂíÌ壬ºóÕ߶ԼÇÒäºÍÈÏÖª¹¦ÄÜÖÁ¹ØÖØÒª¡£¡±
ÄÇô£¬·ÊÅÖÊÇ·ñÕæµÄ»áÓ°Ïì´óÄԵļÇÒä´¢±¸ÉõÖÁÈÏ֪ô£¿2019Ä꣬À´×ÔºÉÀ¼À³¶Ù´óѧҽѧÖÐÐÄ·ÅÉä¿ÆµÄר¼Ò·¢±íÔÚÓ°Ïñѧ¶¥¼¶ÆÚ¿¯RadiologyÉϵÄÑо¿¸ø³öÁ˴𰸡£
Ñо¿ÈËÔ±ÔÚÆÕͨÈËȺµÄÑù±¾ÖУ¬Í¨¹ýMRIÆÀ¹À·ÊÅÖÓë´óÄԽṹ¡ª¡ªÈ«ÄԺ;ֲ¿´óÄÔÌå»ý£¬ÒÔ¼°ÄÔ°×Öʽṹ֮¼äµÄ¹ØÁª¡£2014.03-2018.01Æڼ䣬ÄÉÈëÓ¢¹úÉúÎïÒøÐУ¨UK Biobank£©Ç°Õ°ÐÔ¹Û²ìÑо¿ÖеÄ12087Ãû²ÎÓëÕߣ¨52.8%ΪŮÐÔ£»Æ½¾ùÄêÁä62Ëꣻƽ¾ùBMIΪ26.6 ¡À 4.4 kg/m2£©£¬ËùÓвÎÓëÕß½ÓÊÜÁË3.0T¶àģ̬£¨¼´3DT1ÓëDTI£©ÄÔ³ÉÏñ¡£×ÜÌåÖ¬·¾£¨TBF£©µÄ°Ù·Ö±ÈÓÉÉíÌå×迹ÆÀ¹À¡£
½á¹ûÏÔʾ£¬ÄÐÐÔµÄƽ¾ù×ÜÌåÖ¬·¾(TBF)Ϊ24.4% ¡À 5.5£¬Å®ÐÔµÄƽ¾ù×ÜÌåÖ¬·¾(TBF)Ϊ35.5% ¡À 6.5¡£ÔÚÄÐÐÔÖУ¬TBFÓë³ýÐÓÈʺËÌå»ýÒÔÍâµÄËùÓÐƤÖÊÏ»ÒÖÊ£¨Éñ¾ÔªËùÔÚµÄλÖ㬰üÀ¨ÇðÄÔ¡¢Î²×´ºË¡¢¿ÇºË¡¢Çò×´²Ô°×ÖÊ¡¢º£ÂíºÍ·ü¸ôºË£©Ìå»ý³Ê¸ºÏà¹Ø¡£¶øÔÚÅ®ÐÔÖУ¬TBF½öÓë²Ô°×ÇòÌå»ý³Ê¸ºÏà¹Ø¡£
ͬʱ£¬²»ÂÛÅ®ÐÔ»¹ÊÇÄÐÐÔ£¬TBFÓëÈ«ÄÔFA³ÊÕýÏà¹Ø£¨TBFµÄÿ±ä»¯1SD£¬È«ÄÔFAµÄ±ä»¯·Ö±ðΪ0.05 vs 0.07£©¡£ÔÚÅ®ÐÔÖУ¬TBFÓëÈ«ÄÔMD³Ê¸ºÏà¹Ø£¨TBFÿ·¢Éú1SD±ä»¯£¬È«ÄÔMD -0.07SD£©¡£
Óɴ˿ɼû£¬·ÊÅÖ²»½ö»áµ¼ÖÂƤÖÊÏ»ÒÖÊÌå»ý¼õÉÙ£¬Í¬Ê±»áËðÉËÄÔ°×ÖÊ΢½á¹¹£¬¿Éν¡°Ë«ÖØ´ò»÷¡±¡£
ÄÇô£¬Ö¬·¾ÕæµÄÊ®¶ñ²»Éâô£¿ÆäʵҲ²¢²»Èç´Ë£¬ÕýÈç´ó¼Ò¶¼¶Ôµ¨¹Ì´¼ÓкûµÖ®·ÖÓÐËùÁ˽⣬ͬÑù£¬ÎÒÃÇÒ²Òª±çÖ¤¿´´ýÖ¬·¾£¬¶®µÃÇø·Ö¡°ºÃµÄÖ¬·¾¡±ºÍ¡°»µµÄÖ¬·¾¡±¡£
ÒÔÍùÎÒÃǶ¼ÖªµÀ£¬ÈËÌåÄÚ´æÔÚ×ØÉ«ºÍ°×É«Á½ÖÖÖ¬·¾¡£°×É«Ö¬·¾¶Ñ»ýÔÚƤÏ£¬¸ºÔð´¢´æ¶àÓàÈÈÁ¿£»×ØÉ«Ö¬·¾Ôò¸ºÔð·Ö½âÒý·¢·ÊÅֵİ×É«Ö¬·¾£¬½«ºóÕßת»¯³É¶þÑõ»¯Ì¼¡¢Ë®ºÍÈÈÁ¿£¬±¾Éí²»´¢´æÈÈÁ¿¡£ÆäÖУ¬²¸È鶯Îï´ó¶àÊýÖ¬·¾Ï¸°û¶¼ÊôÓÚ°×É«Ö¬·¾£¬Ð¡¶¯ÎïºÍÈËÀàÐÂÉú¶ùÓдóÁ¿×ØÉ«Ö¬·¾£¬ºóÕßÓµÓдóÁ¿ÏßÁ£Ì壬±È°×É«Ö¬·¾¸üÄܸßЧµØÏûºÄÄÜÁ¿ÎïÖʲúÉúÈÈÁ¿¡£
Òò´ËÔÚ2020Ä꣬·¢±íÔÚ¡¶¿Æѧ¡¤×ª»¯Ò½Ñ§¡·£¨Science Translational Medicine£©ÔÓÖ¾ÉϵÄÑо¿ÈÏΪ£¬Ò»¸öDZÔڵķÊÅÖÖÎÁÆ·½·¨¾ÍÊǽ«Î´ÍêÈ«·¢ÓýΪÈËÀà°×É«Ö¬·¾µÄ½×¶ÎʹÓÃCRISPR-Cas9»ùÒò±à¼¼¼Êõ£¨Ã»´í£¬¾ÍÊÇÈÙ»ñ2020Äêŵ±´¶û»¯Ñ§½±ÊâÈٵġ°Ä§¼ô¡±£©½øÐлùÒò¸ÄÔì³É×ØÉ«Ö¬·¾£¬È»ºó½«×ØÉ«ÑùÖ¬·¾Ï¸°û½øÐÐÒÆÖ²£¬´Ó¶ø´Ù½øÄÜÁ¿ÏûºÄ¡£
ÎÞ¶ÀÓÐż£¬¾ÍÔÚ²»¾ÃÇ°£¬À´×ÔÃÀ¹ú°Â¹Å˹Ëþ´óѧҽѧԺÉñ¾¿ÆѧµÄר¼ÒÔÚ¶¯ÎïʵÑéÖÐ֤ʵ£¬Ã×É«Ö¬·¾¡ª¡ªÒ»ÖÖÐÂÐ͵ÄÖ¬·¾£¬ÔÚ±£»¤´óÄÔ²»ÊܳմôÓ°ÏìÖбز»¿ÉÉÙ¡£Ã×É«Ö¬·¾¾ßÓа×É«Ö¬·¾ºÍ×ØÉ«Ö¬·¾µÄ¹¦ÄÜ£¬²¢ÄÜÔÚÁ½ÕßÖ®¼äת»»£¬¶øÇÒ´Ó·Ö×ÓÉúÎïѧ½Ç¶È£¬³ÉÄêÈËÌåÖеÄ×ØÉ«Ö¬·¾ÓëÕâÖÖÖ¬·¾Ê®·ÖÀàËÆ¡£
Stranahan AM½ÌÊÚÍŶÓÔÚNature CommunicationÔÓÖ¾Éϱ¨¸æ˵£¬ËûÃÇ·¢ÏÖ£¬ÔÚ ¡°ÀæÐÍ¡±Éí²ÄµÄÈËƤÏÂÖ¬·¾ÖУ¬Óë°×É«Ö¬·¾Ï¸°û»ìºÏÔÚÒ»ÆðµÄÃ×É«Ö¬·¾Ï¸°û½éµ¼ÁËƤÏÂÖ¬·¾¶Ô´óÄԵı£»¤¡£
¡°ÀæÐÍ¡±Éí²ÄÖ¸µÄÊÇÍâÖÜÐÍ·ÊÅÖ£¬Ö¬·¾¶à¶Ñ»ýÔÚÍβ¿ºÍÍȲ¿£»¡°Æ»¹ûÐÍ¡±Éí²ÄÖ¸µÄÊÇÖÐÐÄÐÍ·ÊÅÖ£¬Ö¬·¾¶à·Ö²¼ÔÚ¸¹²¿¡£ÆäÖÐÇ°Õ߶à¼ûÓÚÅ®ÐÔ£¬ºóÕ߶à¼ûÓÚÄÐÐÔ¡£ÕâÁ½ÖÖÉí²ÄµÄÐγÉÓ뼤ËØ¡¢ÒÅ´«¡¢ÖÖ×å¡¢ÐÔ±ðºÍÄêÁäµÈÒòËØϢϢÏà¹Ø¡£Òò´ËÔÚÒ×»¼¼²²¡µÈ·½ÃæÒ²ÓÐ×ÅÏÔÖøµÄ²îÒì¡£ÀýÈç¡°Æ»¹ûÐÍ¡±Éí²ÄÒòΪ֬·¾¶à¶Ñ»ýÔÚ¸¹²¿£¬ËùÒÔÒ×»¼¸ßѪѹ¡¢¹ÚÐIJ¡¡¢2ÐÍÌÇÄò²¡¡¢ÖзçÉõÖÁÊÇÈÏÖª¹¦ÄÜϽµ¡£
ȱ·¦¹¦ÄÜÐÔÃ×É«Ö¬·¾µÄСÊóÔÚ¸ßÖ¬ÒûʳµÄÇé¿öϱíÏÖ³öÄÔÄÚС½ºÖÊϸ°û£¨Ñ×֢ϸ°û£©¼¤»îºÍ¼ÓËÙÈÏÖª¹¦ÄÜÕÏ°£¬¶øƤÏÂÖ¬·¾ÒÆÖ²Ôò¿ÉÒÔͨ¹ýÃ×É«Ö¬·¾ÒÀÀµµÄ»úÖƱ£»¤Ð¡ÊóµÄÂýÐÔ·ÊÅÖ¡£Í¬Ê±£¬Ã×É«Ö¬·¾Ï¸°ûÔÚÒÆÖ²ºó¿É»Ö¸´º£ÂíµÄÍ»´¥¿ÉËÜÐÔ£¬ÉÏÊö×÷ÓÃÐèÒª¿¹Ñ×ϸ°ûÒò×ÓIL-4µÄ½éµ¼¡£
Ϊ´Ë£¬¸ÃÑо¿½á¹ûÖ¤Ã÷£¬Ã×É«Ö¬·¾Ï¸°û»òÖ¬·¾Ï¸°û¶ÔÓÚƤÏÂÖ¬·¾µÄÉñ¾±£»¤ºÍ¿¹Ñ××÷ÓÃÊÇ¡°±Ø²»¿ÉÉٵġ±¡£
¼ÈÈ»Á¬Ö¬·¾Ï¸°û¶¼¶ÔÄÔ×ÓÓв»¿É»òȱµÄ×÷Óã¬ÄÇôÔõô³Ô²ÅÊÇ×îºÃµÄÄØ£¿ÔÚÕâÀï¡ÖØÏò´ó¼Ò½éÉÜÒ»ÖÖÐÂÐͽ¡¿µÒûʳ·½°¸¡ª¡ªMINDÒûʳ¡£
2019£¬À´×Ô°Ä´óÀûÑÇÐÂÄÏÍþ¶ûÊ¿´óѧµÄÉñ¾¿Æѧ¼Ò·¢±íÔÚAlzheimer¡¯s & DementiaÔÓÖ¾ÉϵÄÑо¿µ÷²éÁË1220Ãû60ËêÒÔÉϵÄÀÏÄêÈËÔÚ12ÄêÖеÄÒûʳÇé¿ö£¬²¢¼Ç¼ºÍÆÀ¹ÀÁËÆäÈÏÖªÄÜÁ¦¡£½á¹ûÏÔʾ£¬¼á³ÖMINDÒûʳģʽµÄÈË»¼Çá¶ÈÈÏÖªÕÏ°»ò³Õ´ôÖ¢µÄ·çÏÕϽµÁË53%£¨OR = 0.47£¬95% CI 0.24-0.91£©£¬¶ø¶ÔÓÚÖ»ÊÇÒ»¶¨³Ì¶È²ÎÕÕÕâÖÖÒûʳ·½°¸µÄ²ÎÓëÕßÀ´Ëµ£¬ÕâÖÖ·çÏÕÒ²½µµÍÁË35%£¡
×îºó£¬ÔÚ´ËÒ²·îÉÏMINDÒûʳʳÆ×Öаüº¬ÓÐ15ÖÖʳÎ°üÀ¨10ÖÖ¡°½¡ÄÔʳÎ¡ª¡ªÂÌÒ¶Ê߲ˡ¢ÆäËüÊ߲ˡ¢¼á¹û¡¢½¬¹û¡¢¶¹Àࡢȫ¹ÈÀà¡¢Óã¡¢¼ÒÇÝ¡¢éÏéÓͺÍÆÏÌѾƣ¬ÒÔ¼°ÎåÖÖ²»½¡¿µÊ³Îï°üÀ¨ºìÈâ¡¢»ÆÓͺÍÈËÔì»ÆÓÍ¡¢ÄÌÀÒ¡¢¸âµãºÍÌðʳ¡¢ÓÍըʳƷ»òÕß¿ì²Í¡£¶øÏëÒª´óÄÔ½¡¿µµÄ¼òµ¥×ö·¨¾ÍÊǾ¡Á¿Ñ¡Ôñ¡°½¡ÄÔʳÎ¶ø±ÜÃâ²»½¡¿µµÄʳÎï¡£
×ÛÉÏ£¬ÉíÌåÖеÄÖ¬·¾Ï¸°û¶ÔÈÏÖª¹¦ÄÜÆð×ÅÖØÒªµÄ×÷Óá£ÏëÒªÀÏÀ´²»ºýÍ¿£¬ÎÒÃDZØÐëÒªÔö¼ÓÌåÄڵġ°ºÃÖ¬·¾¡±±ÈÀý£¬¶ø½¡¿µµÄÒûʳѡÔñÊÇÎÒÃÇÄÜʵÏÖÉÏÊöÄ¿±êµÄ×î¼Ñ;¾¶¡£
²Î¿¼ÎÄÏ×£º
1. Komal Sodhi et al£¬ Role of Adipocyte Na£¬K-ATPase Oxidant Amplification Loop in Cognitive Decline and Neurodegeneration£¬ iScience (2021). DOI£º 10.1016/j.isci.2021.103262
2. Dekkers IA£¬ et al. Obesity£¬ Brain Volume£¬ and White Matter Microstructure at MRI£º A Cross-sectional UK Biobank Study. Radiology. 2019 Jun;291(3)£º763-771. doi£º10.1148/radiol.2019181012.
3. Guo DH£¬ et al. Beige adipocytes mediate the neuroprotective and anti-inflammatory effects of subcutaneous fat in obese mice. Nat Commun. 2021 Jul 30;12(1)£º4623. doi£º 10.1038/s41467-021-24540-8.
4. Hosking DE£¬ et al. MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study. Alzheimers Dement. 2019 Apr;15(4)£º581-589. doi£º 10.1016/j.jalz.2018.12.011.
׫ÎÄ£üDr. Apathy±à¼£üPP
39½¡¿µÍø(www.39.net)ר¸å£¬Î´¾ÊéÃæÊÚȨÇëÎðתÔØ¡£
ÓÃÓÚ·ÊÅÖ»òÌåÖس¬ÖØ»¼Õߣ¨ÌåÖØÖ¸Êý¡Ý24£©µÄÖÎÁÆ¡£°ÂÀû˾ËûƬ½áºÏ΢µÍÈÈÄÜÒûʳÊÊÓÃÓÚ·ÊÅÖºÍÌåÖس¬ÖØÕß°üÀ¨ÄÇЩÒѾ³öÏÖÓë·ÊÅÖÏà¹ØµÄΣÏÕÒòËصĻ¼Õߵij¤ÆÚÖÎÁÆ¡£[Ïêϸ]
È¥¿´¿´ £¤200.5Éó¤ÁìÓò£ººôÎüϵͳ¼²²¡(È磺·¢ÈÈ¡¢¿ÈËÔ¡¢¿©Ñª¡¢ÐØÍ´¡¢·¢ç¤¡¢À§ÄÑ£¬ÐØÃÆ¡¢Ðļ¡¢´ò÷ý¡¡)¼°ÀÏÄ겡(ÈçÂýÐÔÖ§Æø¹ÜÑס¢Ö§Æø¹ÜÏø´¡¢Ö§¹ÜÀ©ÕÅ¡¢·ÎÑס¢·Î½áºË¡¢Ðز¿Ö×Áö¡¢ºôÎüË¥½ß¡¢¸ßѪѹ¡¢¹ÚÐIJ¡¡¢ÐÄÂÉʧ³£¡¢Î¸³¦¹¦ÎÉÂÒ¡¢ÌÇÄò²¡¡¢Í´·ç¡¢¹ÇÖÊÊèËÉ¡¢·çʪ¡¡)µÄÕï¶Ï¼°ÖÎÁÆ
Éó¤ÁìÓò£ºÉó¤¸÷ÖÖÒÉÄѸ´ÔÓƤ·ô²¡,ÓÈÆäÊÇÃ沿ËðÈÝÐÔƤ·ô²¡(ðî´¯¡¢Ãµ¹åðî´¯¡¢°×ñ°·ç¡¢»ÆºÖ°ßµÈ)¡¢»¯×±Æ·Æ¤·ô²¡¡¢¹ýÃôÐÔƤ·ô²¡µÈ¼²²¡µÄÕï¶ÏºÍ´¦Àí,ÒÔ¼°»¯×±Æ·ÈËÌ尲ȫÐԺ͹¦Ð§ÆÀ¼Û¡£
Éó¤ÁìÓò£ººôÎü¼²²¡¡¢Ð¡¶ùÍç¿È¡¢Ïø´£¬¾²ú²¡¡¢ÐÄÄÔѪ¹Ü²¡¡¢ÌÇÄò²¡¡¢¸Îµ¨²¡µÈ¡£×ÔÄâ˫ʯÌÀÖÎÁÆÔ·¢ÐÔ¸ßѪѹ¡¢Ð¡½ðµ¤ÖÎÁÆÂýÐÔ¸ÎÑ×ѪðöÖ¤ÁÆЧÏÔÖø¡£